ATS' Dermagraft Unapprovable For Diabetic Foot Ulcers Without New Study
This article was originally published in The Gray Sheet
Executive Summary
Advanced Tissue Sciences is discussing with FDA the design of an additional clinical trial that the agency is requiring prior to approval of the firm's Dermagraft bioengineered human skin graft in the treatment of diabetic foot ulcers.
You may also be interested in...
PMA Supplement Guidance Finally Finalized, But Questions Remain
FDA finalized guidelines Dec. 11 explaining what PMA supplement submissions are required for certain product modifications, largely mirroring 2007 draft guidance that device makers considered "incomplete.
PMA Supplement Guidance Finally Finalized, But Questions Remain
FDA finalized guidelines Dec. 11 explaining what PMA supplement submissions are required for certain product modifications, largely mirroring 2007 draft guidance that device makers considered "incomplete.
Cyberonics Treatment IDE To Allow For Limited Use Of VNS For Depression
Cyberonics' strategy of obtaining a treatment IDE for its vagus nerve stimulation VNS Therapy for depression will place the device in the hands of more physicians, but will not necessarily help reverse FDA's non-approvable decision